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Surgical treatment of hemangiomas and vascular malformations 
in functional areas
A bstract Hemangiomas and vascular malformations 
(VM) in functional areas can be treated by a variety of 
methods. Because of the natural involution of hemangio­
mas, a n on-agressive approach is recommended. Active 
therapy is necessary only in cases where a function is 
affected such as vision, respiration, hearing, and feeding. 
Psychological problems can be an indication for early 
excision, and psychological/cosmetic reasons in the pres­
ence of fibrofatty tissue residues when the hemangioma has 
been involuted for late excision. In contrast to hemangio­
mas, no involution is to be expected for VMs, so that 
therapy depends mainly on the occurrence of functional 
problems and/or serious complications. Surgical excision 
still has a place, however, the indications are limited.
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Introduction
According to Mulliken, vascular lesions can be classified as 
hemangiomas or vascular malformations (VM) based on 
their clinical and histologic characteristics [8, 11]. Heman­
giomas are cellular tumors, exhibiting endothelial-cell pro­
liferation. They are common occurring in about 12% of all 
children under 1 year of age. They typically and exclusively 
appeal* in early infancy, often beginning as a small macula 
and growing rapidly in the 1st to 4th weeks, then under­
going fatty replacement and involution by adolescence.
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About 50% of all hemangiomas are involuted by the age 
of 5 years, about 100% by the age of 12. The histologic 
appearance depends on the stage of evolution: early lesions 
are characterized by proliferating endothelial cells and 
contain large numbers of mast cells. VMs are less fre­
quently seen, in about 0.5% of all newborns. These lesions 
result from abnormal blood or lymphatic vessel morpho­
genesis. Histologically, VMs are characterized by normal 
endothelial cells and normal numbers of mast cells through­
out their history. They are present at birth, but may not 
become clinically apparent until late infancy or childhood. 
Under the influence of hormones, trauma, and sepsis, 
changes may occur. Their growth is commensurate with 
that of the patient, and they do not involute. VMs are 
classified by the predominant type of vessel involved and 
include capillary (CM), venous (VeM), lymphatic (LM), 
and arteriovenous malformations (AVM). Another way of 
classifying vascular lesions is by their flow characteristics: 
hemangiomas, as well as CMs, VeMs, and LMs, are low- 
flow lesions while AVMs are high-flow lesions.
Differentiation between a hemangioma and a VM is very 
important for management and therapy, but may sometimes 
be quite difficult. The history and physical examination 
remain the most important diagnostic parameters. Ultra­
sound can be helpful; a duplex scan may aid in differentiat­
ing between low- and high-flow malformations. Magnetic 
resonance imaging (MRI) can also help differentiate be­
tween VeMs and hemangiomas [1]. The diagnosis of a VeM 
may be suggested by the presence of enlarged venous lakes 
and phleboliths. Arteriography remains the standard inves­
tigation for AVMs, but is useless for VeMs. Recently, 
experimental work has revealed that urinary levels of 
basic fibroblast growth factor, an angiogenic factor, are 
abnormally elevated during the proliferating phase of 
hemangiomas but return to normal during involution of 
the lesions or after therapeutic intervention. This may be a 
promising new method for distinguishing hemangiomas 
from VMs [4, 18].
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Fig. 1 a Fourteen-month-old boy with hemangioma on dorsal surface 
of nose, b After surgical debulking of hemangioma
Fig. 2 a Six-year-old boy with hemangioma of tip of nose, b After 
surgical debulking of hemangioma
Therapy of hemangiomas
In 1938, Lister was the first to publish a prospective study 
in which he stated that all fas t-gr owing vascular tumors 
showed natural involution, on average at the age of 5 years 
[9]. Because of this natural involution of hemangiomas, a 
non-aggressive approach is recommended. In earlier years a 
variety of therapies were used: artificial ulceration, electro­
lysis, thermocauterization, radiotherapy, and compression. 
It is always important to tell the parents that surgery is not 
possible without scarring, while natural involution is gen­
erally followed by an inconspicuous scar. Treatment of
these benign lesions with radiotherapy is obsolete in view 
of the probability of developing skin cancer.
Active therapy is necessary only for complications or 
hemangiomas in special functional locations (eyelid, throat, 
mouth, etc.); growing hemangiomas at these locations 
sometimes interfere with vision, respiration, feeding, and 
hearing. Active therapy consists initially of corticosteroids, 
which can be given locally or systemically [14]; the success 
rate is reported to be in the range of 30% to 90% [11]. If 
corticosteroid therapy has failed, interferon c a n b e u se d a sa  
second-line treatment [3]. The penetrating ability of lasers 
limits their use in the treatment of hemangiomas [6, 17, 19]. 
Psychological problems in cases of severe disfigurement 
may be an indication for early surgical excision [10]. 
Cosmetically disturbing residual fibrofatty tissue and ex­
cess skin after involution of the hemangioma may be 
another indication for late surgical excision.
Case reports
Case 1 A 14-month-old boy presented with a hemangioma of the dorsal 
surface of the nose. No impairment of vision was noted. After carefully 
weighing the pros and cons, surgical debulking was performed mainly 
for psychological/cosmetic reasons. Primary closure was obtained 
(Fig. l a  and b).
Case 2 A 6-year-old boy had a partially involuted hemangioma of the 
tip of the nose. No functional problems existed, but for psychological 
reasons the hemangioma was debulked and primary closure was 
carried out (Fig. 2 a and b).
Case 3 For psychological reasons, a hemangioma of the upper lip of a
5-year-old boy was treated by excision after ligation of the feeding 
superior labial artery (Fig. 3 a and b).
Case 4 A 14-month-old girl presented with multiple hemangiomas of 
the neck, shoulder, back, and buttocks. The hemangioma in the neck, 
which was small-based and protruding, was very distressing and 
therefore was simply excised. All the others were left alone for 
spontaneous regression.
Therapy of VMs
In contrast to hemangiomas, no involution is to be expect­
ed, so that therapy is mainly dependent on functional 
problems and/or serious complications: persisting pain, 
ulceration, and/or bleeding.
Therapy is differentiated according to the kind of mal­
formation: CMs are best treated by laser therapy [6], while
Fig. 3 a Five-year-old boy with 
hemangioma of upper lip. b After 
excision of lesion following liga­
tion of feeding labial artery
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the main therapy for VeMs localized in the extremities 
consits of compression. Bulk reduction by means of sclero­
therapy (alcohol, Ethibloc) or laser photocoagulation is 
often utilized in the head and neck region [4, 5, 15, 20], 
Smaller, localized VeMs may better be excised. In our 
departments, cystic LMs are preferably treated surgically, 
although sclerosing therapies (Ethibloc, OK432) are also 
recommended by other authors [2, 12]. AVMs (high-flow 
lesions) are treated by embolization combined with surgical 
excision [16]. Surgical therapy alone leads to a high 
frequency of recurrence by means of collateral vessels. 
Ligation of the main vascular pedicle prohibits emboliza­
tion in case of recurrence, so this is not recommended. 
Combination therapy is essential [7, 11, 13]; in large 
resections it may be necessary to reconstruct the defect 
that has been created with a free, revascularized tissue 
transfer [11, 20, 21].
Case reports
Case 5 An 11-year-old girl was referred because of congenital 
venectasias on the medial side of the lower leg. A small blue spot 
was observed directly after birth, which grew proportionally with the 
child. She later complained of a swelling that became painful 1 year 
before referral. On examination, a small mass with 2 cm in diameter 
was seen under the left knee. Medially, distal and lateral to this 
swelling, pretibial venectasias were observed. However, no signs of 
venous insufficiency or edema were discernible. The swelling had a 
normal temperature and no thrill was noted. A duplex scan suggested 
an AVM, while the clinical picture suggested only a local VeM. This 
was confirmed by additional MRI/MR angiography (MRA). Because 
of her complaints, the decision was made to excise the abnormal varix 
and perform sclerotherapy for the remaining venectasias. Histologic 
examination revealed a VeM with one recent and multiple older 
thrombi. After the operation the patient was asymptomatic.
Case 6 An 11-year-old boy presented with a large swelling of the 
scrotum, which had existed since birth but had grown rapidly during 
the last 12 months. Ulceration and bleeding occurred regularly.
Fig. 4 a Eleven-year-old boy with arteriovenous malformation (AVM) 
of scrotum, b Digital subtraction arteriography confirming diagnosis of 
AVM. c After embolization and excision of AVM
Inspection revealed a large capillary malformation of the scrotal and 
perineal region. In addition, a large swelling was seen in the scrotum. 
Duplex and digital subtraction arteriography confirmed the diagnosis 
of an AVM. Embolization and resection was carried out; because of the 
proximity of the anal sphincter, the resection in the perineal region was 
incomplete. The postoperative recovery was uneventful. At 4-year 
follow-up increased bulging of the perineal area was seen. Although 
the scrotal area remains free, the perineal skin again shows ulceration. 
MRJ/MRA and angiography was again performed and showed a 
recurrence of the AVM in the perineum. Because of increasing physical 
and psychological problems, it was decided to embolize and reresect in 
the near future (Fig. 4 a -c ) .
In conclusion, it should be borne in mind that only a 
very small percentage of patients with hemangiomas re­
quire active intervention, however, in a small subpopulation 
surgical excision may be an appropriate and justified 
treatment. These cases include endangerment of vision, 
hearing, respiration, or frequent bleeding, as well as psy­
chological problems because of severe disfigurement of the 
face. VMs occur less frequently, and in many instances no 
treatment or conservative management is preferred. Among 
several therapeutic modalities, surgery still has a place in 
localized VeMs and cystic LMs and in combination with 
embolization for AVMs.
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